PROMETH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prometh, and when can generic versions of Prometh launch?
Prometh is a drug marketed by Alpharma Us Pharms, Pai Holdings, Actavis Mid Atlantic, G And W Labs Inc, Chartwell Rx, Polymedica, Cenci, Abbott, Am Regent, Bedford Labs, Epic Pharma Llc, Hikma, Hospira, Marsam Pharms Llc, Mylan Institutional, Sandoz, Teva Pharms Usa, Watson Labs, Wockhardt Bio Ag, Xgen Pharms, Able, Annora Pharma, Cosette Pharms Nc, Padagis Israel, Sun Pharma Canada, Watson Labs Inc, Amneal Pharms, Kv Pharm, Pharm Assoc, Quagen, Strides Pharma, Whiteworth Town Plsn, Amneal Pharms Ny, Aurobindo Pharma Usa, Chartwell Molecular, Impax Labs, Ivax Sub Teva Pharms, Kvk Tech, Prinston Inc, Pvt Form, Rising, Sun Pharm Inds Inc, Sun Pharm Industries, Tablicaps, Teva, Zydus Pharms Usa, Pharmobedient, Ani Pharms, Hetero Labs Ltd Iii, Xttrium Labs Inc, and Wockhardt. and is included in one hundred and ten NDAs.
The generic ingredient in PROMETH is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROMETH?
- What are the global sales for PROMETH?
- What is Average Wholesale Price for PROMETH?
Summary for PROMETH
| US Patents: | 0 |
| Applicants: | 51 |
| NDAs: | 110 |
| Drug Prices: | Drug price information for PROMETH |
| Drug Sales Revenues: | Drug sales revenues for PROMETH |
| DailyMed Link: | PROMETH at DailyMed |
US Patents and Regulatory Information for PROMETH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 091054-002 | Aug 30, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 209177-001 | Jun 30, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Annora Pharma | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SUPPOSITORY;RECTAL | 216446-001 | Nov 2, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
